Mid-Atlantic BioTherapeutics has filed a notice of an exempt offering of securities to raise $5 Million in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Mid-Atlantic BioTherapeutics is raising up to $5 Million in new funding. Sources indicate that as part of senior management Chief Executive Officer, David Horn played…